Publications by authors named "Youcef M Rustum"

Claim this Profile
T
Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential.
Aseel O Rataan, Yan Xu, Sean M Geary, Yousef Zakharia, Eman S Kamel, Youcef M Rustum

Cancer Treat Res Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy.
Youcef M Rustum, Ryan Reis, Tara M Rustum

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets.
Samuel Swearson, Aseel O Rataan, Steven Eliason, Brad A Amendt, Yousef Zakharia, Youcef M Rustum

Int J Mol Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Role of Selenium in the Treatment of Cancer and Viral Infections.
Aseel O Rataan, Sean M Geary, Yousef Zakharia, Youcef M Rustum, Aliasger K Salem

Int J Mol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma-Bench-to-Bedside Therapy.
Youcef M Rustum, Sreenivasulu Chintala, Farukh A Durrani, Arup Bhattacharya

Int J Mol Sci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.
Yousef Zakharia, Arup Bhattacharya, Youcef M Rustum

Oncotarget· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrico Mihich, MD: In Memoriam (1928-2016).
Margaret Foti, Youcef M Rustum

Cancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive expression of HIF-α plays a major role in generation of clear-cell phenotype in human primary and metastatic renal carcinoma.
Károly Tóth, Sreenivasulu Chintala, Youcef M Rustum

Appl Immunohistochem Mol Morphol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice.
Sathish K R Padi, Qunshu Zhang, Youcef M Rustum, Carl Morrison, Bin Guo

Gastroenterology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges.
Venugopalan Kasturirangan, Bindu M Nair, Muhammed T S Kariapper, Wojciech G Lesniak, Wei Tan, Youcef M Rustum

Nanotoxicology· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
Xiang Ling, Shousong Cao, Qiuying Cheng, James T Keefe, Youcef M Rustum

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Sreenivasulu Chintala, Tanbir Najrana, Karoly Toth, Shousong Cao, Farukh A Durrani, Youcef M Rustum

BMC Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ugt1a is required for the protective effect of selenium against irinotecan-induced toxicity.
Shousong Cao, Farukh A Durrani, Youcef M Rustum, Y Eugene Yu

Cancer Chemother Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmented therapeutic efficacy of irinotecan is associated with enhanced drug accumulation.
Rami G Azrak, Shousong Cao, Farukh A Durrani, Karoly Toth, Arup Bhattacharya, Youcef M Rustum

Cancer Lett· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1.
Yan Hu, Mary L Spengler, Karen K Kuropatwinski, Maria Comas-Soberats, Marilyn Jackson, Youcef M Rustum

Oncotarget· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Architectural heterogeneity in tumors caused by differentiation alters intratumoral drug distribution and affects therapeutic synergy of antiangiogenic organoselenium compound.
Youcef M Rustum, Károly Tóth, Mukund Seshadri, Arindam Sen, Farukh A Durrani

J Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts.
Shousong Cao, Farukh A Durrani, Karoly Toth, Youcef M Rustum, Mukund Seshadri

Oral Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts.
Sreenivasulu Chintala, Károly Tóth, Ming-Biao Yin, Arup Bhattacharya, Sylvia B Smith, Youcef M Rustum

Chemotherapy· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer.
Arup Bhattacharya, Steve G Turowski, Ivan Dominguez San Martin, Ashwani Rajput, Youcef M Rustum

Anticancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers.
Maher S Saifo, Donald R Rempinski, Youcef M Rustum, Rami G Azrak

Mol Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.
Sreenivasulu Chintala, Károly Tóth, Shousong Cao, Farukh A Durrani, Mary M Vaughan, Youcef M Rustum

Cancer Chemother Pharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double immunohistochemical staining method for HIF-1alpha and its regulators PHD2 and PHD3 in formalin-fixed paraffin-embedded tissues.
Mary M Vaughan, Karoly Toth, Sreenivasulu Chintala, Youcef M Rustum

Appl Immunohistochem Mol Morphol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markers.
Fengzhi Li, Qiuying Cheng, Xiang Ling, Aimee Stablewski, Lei Tang, Youcef M Rustum

Am J Pathol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of colon cancer growth by methylselenocysteine-induced angiogenic chemomodulation is influenced by histologic characteristics of the tumor.
Arup Bhattacharya, Károly Tóth, Arindam Sen, Mukund Seshadri, Shousong Cao, Youcef M Rustum

Clin Colorectal Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer.
Marwan G Fakih, Lakshmi Pendyala, Gerald Fetterly, Karoli Toth, James A Zwiebel, Youcef M Rustum

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis